PatrickJLeaveyMD
Pediatric Hematology & Oncology • Dallas, TXProfessor of Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Leavey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-456-2382Fax+1 214-456-6133
Education & Training
University of ColoradoResidency, Pediatrics, 1996 - 1999- University of ColoradoFellowship, Pediatric Hematology/Oncology, 1992 - 1995
Royal College of Surgeons IrelandClass of 1986
Certifications & Licensure
TX State Medical License 1998 - 2026
CO State Medical License 1995 - 2001- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Start of enrollment: 2019 Oct 03
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- 217 citationsDose-intensified compared with standard chemotherapy for nonmetastatic ewing sarcoma family of tumors: A children's oncology group studyLinda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang
Journal of Clinical Oncology. 2009-05-20 - 8 citationsDeep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction.Xinyi Zhang, Shidan Wang, Erin R Rudzinski, Saloni Agarwal, Ruichen Rong
The American Journal of Pathology. 2022-06-01 - 127 citationsPrognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the children's oncology groupPatrick J. Leavey, Leo Mascarenhas, Neyssa Marina, Zhengjia Chen, Mark Krailo
Pediatric Blood & Cancer. 2008-09-01
Press Mentions
Vignettes of Vermonters Adapting to Life in a PandemicMarch 25th, 2020- Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 10th, 2016
Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 7th, 2016
Grant Support
- Metabolic Profiling in Pediatric Fusion Positive SarcomaNIH-NCI Center for Cancer Research2018–2020
- Using imaging and computational tools to improve risk stratification in children with bone cancerCancer Prevention and Research Institute of Texas (CPRIT)2015–2019
Professional Memberships
- Fellow
- American Society of Pediatric Hematology/OncologyPresident
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
